KalVista Pharmaceuticals (KALV) Cash & Current Investments (2016 - 2024)
Historic Cash & Current Investments for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $268.3 million.
- KalVista Pharmaceuticals' Cash & Current Investments changed N/A to $268.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $268.3 million, marking a year-over-year change of. This contributed to the annual value of $210.4 million for FY2024, which is N/A changed from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Cash & Current Investments of $268.3 million as of Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Cash & Current Investments ranged from a high of $268.3 million in Q4 2024 and a low of $50.3 million during Q1 2021
- For the 4-year period, KalVista Pharmaceuticals' Cash & Current Investments averaged around $117.5 million, with its median value being $91.9 million (2020).
- In the last 5 years, KalVista Pharmaceuticals' Cash & Current Investments plummeted by 4021.68% in 2020 and then skyrocketed by 4138.91% in 2024.
- KalVista Pharmaceuticals' Cash & Current Investments (Quarter) stood at $55.9 million in 2020, then decreased by 9.96% to $50.3 million in 2021, then soared by 105.07% to $103.2 million in 2023, then skyrocketed by 160.09% to $268.3 million in 2024.
- Its Cash & Current Investments stands at $268.3 million for Q4 2024, versus $135.8 million for Q4 2024 and $174.3 million for Q3 2024.